Monod Bio is at the forefront of using de novo protein design methods and the lucCage technology. Designed to create the next generation of biosensors.
We are excited to announce a $1.5M grant from the Gates Foundation to develop a rapid diagnostic for tuberculosis using our AI-based protein design platform which allows for the creation of NovoBodies™ https://t.co/ro0UJV8aHm
#Biotechnology#ProteinDesign#GlobalHealth
Happy New Year from Monod Bio! 🎉
As we welcome 2025, we’re grateful for the collaboration and innovation of the past year and excited to continue advancing our mission. Here’s to another year of growth!
#HappyNewYear2025#BiotechInnovation
This Thanksgiving, we’re grateful for innovation, collaboration, and the support of our incredible community. Whether you're a partner, team member, or follower, you’ve been part of our journey, and we couldn’t do it without you.
#HappyThanksgiving from all of us at #MonodBio!
This Halloween, we’ve unleashed a dino-scientist to join our lab! 🦖Whether it’s designing proteins or helping uncover groundbreaking tools for today’s world, it’s all in a day’s work for our prehistoric powerhouse.
#HappyHalloween from Monod Bio! 🎃
#SpookyScience#JurassicLab
Want to know more about Monod Bio's first de novo protein, powered by David Baker's Nobel-winning tech? LuxSit is a luciferase designed from scratch, offering unmatched brightness and stability for lab use. Available in split formats too! Check it out: https://t.co/jasrS1WUpV
Check out the @UNAM_MX article on Monod Bio’s CEO and co-founder, Daniel Silva, PhD! It covers his journey from UNAM to co-founding Monod Bio with #NobelPrize2024 Laureate David Baker and their work revolutionizing #diagnostics with #AI-designed proteins.
https://t.co/pr3UOn1MDd
We're proud to see our CEO, Daniel Silva, featured in @el_pais discussing his work with 2024 Chemistry Nobel Laureate David Baker! At Monod Bio, we use the same computational protein design to create cutting-edge lab tools & diagnostics. #NobelPrize2024
https://t.co/4a2bwVlNjW
Check out @cenmag's new article on the Nobel Prize in protein design! We're proud of David Baker’s recognition and thrilled to see insights from our execs, Daniel Silva Manzano and Alfredo Quijano Rubio. Monod Bio has been innovating since our 2021 launch!
https://t.co/Z0Q0616sEx
Monod Bio, a 2021 spinoff from David Baker's lab, congratulates its Co-Founder & Advisor, Dr. Baker (UW), on winning the 2024 Nobel Prize in Chemistry for pioneering computational protein design. AI visionaries Hassabis & Jumper also share the prize. https://t.co/q68rYevaa2
CRP NovoLISA is here!
We’re thrilled to introduce #NovoLISA, a cutting-edge #biosensor assay platform designed for research applications! NovoLISA delivers rapid, single-step results in just 15 minutes—no wash steps required.
https://t.co/oZKjTEgnu6
https://t.co/AMV8fkYClh
Exciting news! 🎉 We're thrilled to announce the launch of our new online ordering platform. Now, you can easily browse, select, and order LuxSit™ Pro products directly from our website.
Visit us here: https://t.co/AS2E68Uawt 🌐
We're excited to announce the release of our first product, LuxSit™ Pro, the world's first fully de novo luciferase. Order here: https://t.co/ck4W5kqOAr. See today's press release here: https://t.co/654OS8KBa6
#luciferase#denovoproteindesign#LuxSitPro
Happy 4th of July! 🌟 At Monod Bio, we're wishing everyone a safe and joyful holiday filled with celebration and reflection. Happy Independence Day! #IndependenceDay#4thOfJuly#Celebrate#MonodBio
We're thrilled to be part of hosting the @OUTbio Seattle Pride Party at Dexter Yard tomorrow! Join us for stunning rooftop views along with delicious food & beverages. Happy Pride! 🌈 #SeattlePride#biotech#PrideMonth
Congratulations to Élyse Fischer!🚴♀️
We're thrilled to announce that Élyse Fischer has BMR's annual May Bike Month Challenge... for the second year in a row! 🎉
We're incredibly proud to see our talented staff being recognized outside of the lab. Keep pedaling, Élyse! #BikeMonth
We are delighted to announce that our advisor, Dr. Gonçalo Bernardes, has been honored with the 2024 Corday-Morgan Mid-Career Prize for Chemistry by @RoySocChem. This prestigious award highlights Dr. Bernardes' groundbreaking work in targeted therapeutics.
https://t.co/RXZFPjzxmt
At #BIO2024, our CEO and Co-Founder, Daniel-Adriano Silva, PhD, spoke at the AI's Impact on Oncology Cancer Drug Development panel along with other CEOs. During the panel, he discussed the relevance of our technology to the development of companion diagnostics. @IamBiotech#AI
And that's a wrap to #BIO2024!
This year two of our founders, CEO, Dr. Daniel Silva Manzano, & COO, Dr. David Shoultz, were able to participate. In addition, our Sr Director of BD & Commercialization, Matthew Brown, was in attendance. We were pleased to engage during this event!
Join us @TechAllianceWA's Seattle AI Investment Summit + Showcase on June 10-11! Our COO and Co-Founder, Dr. David Shoultz, will be presenting during the Startup Showcase. We're thrilled to explore the impacts of #AI technology on the #biotech ecosystem.
https://t.co/0LHgzPAvR0